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Abstract
Introduction: Rheumatoid arthritis (RA) is a chronic inflammatory and destructive disease of the joint. The synovial
lining consists of two main types of cells: synovial fibroblasts and macrophages. The macrophage-derived cytokine
TNFa stimulates RA synovial fibroblasts to proliferate and produce growth factors, chemokines, proteinases and
adhesion molecules, making them key players in the RA disease process. If proteins are not correctly folded, cellular
stress occurs that can be relieved in part by increased degradation of the aberrant proteins by the proteasome or
autophagy. We hypothesized that the activity of the protein degradation pathways would be increased in response
to TNFa stimulation in RA synovial fibroblasts compared with control fibroblasts.
Methods: Endoplasmic reticulum (ER) stress markers were examined in synovial fibroblasts by immunoblotting and
PCR. Use of the autophagy and proteasome protein degradation pathways in response to TNFa stimulation was
determined using a combination of experiments involving chemical inhibition of the autophagy or proteasome
pathways followed by immunoblotting for the autophagy marker LC3, measurement of proteasome activity and
long-lived protein degradation, and determination of cellular viability.
Results: RA synovial fibroblasts are under acute ER stress, and the stress is increased in the presence of TNFa.
Autophagy is the main pathway used to relieve the ER stress in unstimulated fibroblasts, and both autophagy and
the proteasome are more active in RA synovial fibroblasts compared with control fibroblasts. In response to TNFa,
the autophagy pathway but not the proteasome is consistently stimulated, yet there is an increased dependence
on the proteasome for cell viability. If autophagy is blocked in the presence of TNFa, an increase in proteasome
activity occurs in RA synovial fibroblasts but not in control cells.
Conclusions: TNFa stimulation of synovial fibroblasts results in increased expression of ER stress markers. Survival
of synovial fibroblasts is dependent on continuous removal of proteins by both the lysosome/autophagy and
ubiquitin/proteasome protein degradation pathways. Both pathways are more active in RA synovial fibroblasts
compared with control fibroblasts. These results may provide a better understanding of the mechanism of TNFa
on prolonging the survival of synovial fibroblasts in RA tissue.
Introduction
Rheumatoid arthritis (RA) is a chronic disease character-
ized by inflammation of the synovial membrane lining
the joints, leading to cartilage and joint destruction. The
synovial lining is composed of macrophages, B cells, T
cells and synovial fibroblasts. The synovial fibroblasts
are greatly expanded in number via a process driven by
cytokines, especially the macrophage-derived TNFa.
The cytokine TNFa stimulates proliferation and the
production of additional cytokines, proteases and adhe-
sion molecules. The underlying disease mechanism of
RA is not understood, although resistance of the syno-
vial fibroblasts to TNFa-induced apoptosis has been
recognized as an important factor [1].
Fibroblasts are highly metabolic cells, synthesizing
components of the extracellular matrix as well as pro-
teases capable of degrading the extracellular matrix. For
example, it is estimated that each cell can synthesize up
to 3.5 million procollagen molecules per day [2]. Newly
synthesized proteins that are destined for secretion or
insertion into the plasma membrane are translocated
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into the endoplasmic reticulum (ER), where they
undergo folding, post-translational modifications and
examination by a quality control mechanism. Misfolded
proteins are ubiquitinated and retrotranslocated by cha-
perone proteins to the cytosol, where they are degraded
by cytosolic proteasomes. This process is known as
endoplasmic reticulum-associated degradation [3]. ER
stress occurs when levels of misfolded proteins exceed
the capacity of the protein folding and endoplasmic reti-
culum-associated degradation systems, or when there is
a change in the calcium regulation or oxidative stress in
the ER. In this case, the unfolded protein response
(UPR) is triggered. There are three pathways involved in
the initiation of the UPR: protein kinase-like endoplas-
mic reticulum kinase (PERK), the inositol-requiring
transmembrane kinase and endonuclease 1a (IRE1a),
and the activation of transcription factor 6 (ATF6). The
UPR involves phosphorylation of the translation initia-
tion factor eukaryotic initiation factor 2a (eIF2a), result-
ing in inhibition of most new protein synthesis,
activation of the transcription factor XBP-1 and
increased expression of ER chaperone proteins such as
Bip/GRP78. These changes enable the cell to repair mis-
folded proteins and upregulate the proteasomal degrada-
tion system to eliminate aberrant proteins [4].
If the UPR cannot relieve the ER stress, a lysosome-
dependent degradation process known as autophagy
may be activated [5]. Although autophagy is best known
for its role in generating amino acids and energy
required for cell survival during periods of nutrient
deprivation and hypoxia, it has also been implicated as a
pathway for the elimination of aberrant proteins. Macro-
autophagy is generally considered to be the most impor-
tant pathway through which aberrant proteins are
brought to the lysosome and it is characterized by
sequestration of cytosolic regions in double-membrane
autophagic vesicles (autophagosomes) that are then
fused to and degraded by the lysosome and vacuole sys-
tems [6]. Microautophagy involves the direct uptake of
cytoplasmic compounds by lysosomes. Chaperone-
mediated autophagy utilizes chaperone proteins to
transport proteins bearing a targeting motif to lyso-
somes, where they are translocated across the lysosomal
membrane and degraded.
Excessive ER stress overwhelms the protein degrada-
tion systems and the cell ultimately undergoes apoptosis
through the induction of pro-apoptotic transcription
factors such as ATF4 and CHOP [7].
RA synovial fibroblasts have been demonstrated to be
relatively resistant to ER stress-induced apoptosis when
compared with osteoarthritis fibroblasts, HeLa or
HEK293 cells, and this has been attributed to hyper-
endoplasmic reticulum-associated degradation and the
expression of synoviolin, the TNFa-inducible E3
ubiquitin ligase [8]. More recently, it has been shown
that induction of autophagy also protects RA synovial
fibroblasts from ER stress [9]. Interestingly, several stu-
dies suggest that the ER stress pathway and autophagy
influence each other. However, the relative roles of
autophagy and proteasome-mediated protein degrada-
tion in RA synovial fibroblasts, particularly under the
influence of TNFa, have not been addressed.
In this study, we investigated the influence of TNFa
on the relative role of these degradation pathways in RA
synovial fibroblasts. Our findings suggest that fibroblasts
use both the proteasome and lysosome/autophagy path-
ways to clear excess protein and promote survival.
TNFa induces a partial ER stress response in synovial
fibroblasts and sensitizes them to proteasome inhibition.
TNFa consistently stimulates autophagy but not the
proteasome. When either protein degradation pathway
is inhibited, however, RA synovial fibroblasts initially
compensate for the inhibition by upregulating the alter-
nate protein degradation pathway.
Materials and methods
Synovial tissue
The ethics review committee at the University Health
Network approved the protocol for patient consent and
use of tissues. Synovial tissue from consented patients
was obtained at the time of arthroplasty. Synovial fibro-
blasts were isolated from synovial tissue and maintained
in Opti-MEM (Life Technologies Inc. Carlsbad, CA,
USA) as described elsewhere [10].
Cell culture
Adult dermal fibroblasts and skin lines were purchased
from ATCC (American Type Culture Collection, Mana-
ssas, VA, USA) and maintained as described for the
synovial fibroblasts.
Chemicals
Unless otherwise indicated, all chemicals were from
Sigma-Aldrich (Oakville, ON, Canada).
Immunoblotting
Cells were plated at 1×105 cells per well in six-well cul-
ture dishes. Forty-eight hours later, additives (10 ng/ml
TNFa (R&D Systems Inc., Minneapolis, MN, USA), 12.5
μM chloroquine, 4 mM 3-methyladenine (3-MA), 2 μg/
ml tunicamycin, 0.5 μM MG132 or 0.5 μM epoxomicin)
were included in the culture as indicated for a further 72
hours. Chloroquine is a weak base that accumulates
inside lysosomes, preventing lysosomal acidification. This
results in the inactivation of lysosomal hydrolases [11]
and inhibits the late-stage step in autophagy that involves
the fusion of autophagosomes with lysosomes [12]. In
contrast, 3-MA inhibits class III phosphatidylinositol
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3-OH kinase that is required for autophagosome forma-
tion, an early stage in autophagy [13]. Tunicamycin
blocks the synthesis of all N-linked glycoproteins [14]
and is used to induce ER stress. MG132 is a peptide alde-
hyde proteasome inhibitor, while epoxomicin is a natural
proteasome inhibitor [15]. The concentrations of the
inhibitors we used were based on those reported in the
literature and preliminary titration experiments.
At the time of harvest, the plates were placed on ice,
media were removed, plates were rinsed twice with PBS
and whole cell lysates were prepared by adding SDS-
PAGE lysis buffer (1.1% SDS, 11% glycerol, 88 mM
Tris-HCl, pH 6.8) directly to the wells for 10 minutes.
Lysate was collected and boiled for 5 minutes prior to
shearing the DNA with a 22-gauge needle. A one-tenth
volume of b-mercaptoethanol containing bromophenol
blue loading dye was then added to the lysates such that
the final concentration of loading dye was 0.01%. Pro-
teins were separated by 12% SDS-PAGE, transferred to
Immobilon-P membranes (Millipore Corp., Bedford,
MA, USA) and probed for ser51-phosphorylated eIF2a,
eIF2, microtube-associated light chain 3 (LC3) (Cell Sig-
naling Technology, Beverly, MA, USA), ATF6 (Imgenex,
San Diego, CA, USA), p62 and Bip/GRP78 (BD Bios-
ciences Pharmingen, Mississauga, ON, Canada) in Tris-
buffered saline/5% BSA. Blots were stripped between
probings with Re-Blot-Plus (Chemicon International,
Inc., Temecula, CA, USA). Loading was corrected by
probing the blots for tubulin (NeoMarkers Inc., Fre-
mont, CA, USA). In order to detect monoubiquitinated
and polyubiquitinated proteins using clone FK2 (Enzo
Life Sciences Inc., Farmingdale, CA, USA), it was neces-
sary to decrease the amount of lysate loaded on the gel
to 3 μg and decrease the concentration of BSA in the
hybridization buffer to 1%. Blots were scanned and band
intensities were determined by ImageJ software
(National Institutes of Health, Bethesda, MD, USA).
PCR analysis
Cells (1×105 cells per well) were stimulated in six-well
culture dishes as indicated in the figure legends. Media
were removed and RNA was prepared with the RNeasy
Mini kit (Qiagen Inc., Mississauga, ON, Canada) accord-
ing to the manufacturer’s directions. cDNA was pre-
pared from 50 ng RNA using the Sensiscript RT kit
(Qiagen Inc.). PCR was performed with HotStarTaq
DNA polymerase (Qiagen Inc.). The primers used are
presented in Table 1.
Amplification conditions were 95°C for 15 minutes
followed by: actin, 27 cycles of 92°C for 1 minute, 60°C
for 1 minute, and 72°C for 1 minute; and Xbp-1, Edem1
and CHOP, 31 cycles of 92°C for 1 minute, 58°C for 1
minute, and 72°C for 1 minute, and a final extension
step at 72°C for 10 minutes. The Actin, Edem1 and
CHOP PCR products were resolved on a 1% agarose/
Tris-acetate-EDTA gel. The endoribonuclease activity of
activated IRE1 cleaves a 26-nucleotide Pst1-containing
intron from Xbp1 mRNA. Xbp1 PCR products were
therefore cleaved with Pst1 and resolved on 2% agarose/
Tris-acetate-EDTA gels as an indirect indicator of IRE1
activation. Cleaved Xbp1is an active transcription factor,
implicated in the expression of Edem1. Expression of
Edem1 served as further evidence for IRE1/Xbp1 activa-
tion. Quantification was performed with ImageJ soft-
ware. Relative amounts of Xbp-1 and CHOP were
calculated from normalized actin.
Microscopy
Cells were grown and stimulated on eight-well chamber
slides (Lab-Tek, Nalge Nunc International, Naperville,
IL, USA). The slides were rinsed with PBS and then
fixed with 2% paraformaldehyde for 15 minutes. Slides
were then rinsed three times with PBS prior to the addi-
tion of 0.1% saponin. Slides were rinsed an additional
three times with PBS and then blocked with blocking
buffer (PBS containing 5% BSA, 0.3% Triton-X100) for 1
hour. A 1/500 dilution of primary LC3 antibody (Cell
Signaling Technology) was prepared in antibody dilution
buffer (PBS containing 1% BSA, 0.3% Triton-X100),
added to the slide and left overnight at 4°C. Slides were
rinsed with PBS and then incubated for 1 hour at room
temperature with a 1/500 dilution of goat-a-rabbit sec-
ondary antibody conjugated to Alexa-Fluor 488. A 1/
1,000 dilution of DAPI (Calbiochem, Novabiochem
Corp, San Diego, CA, USA) was added for the final 5
minutes in order to visualize the nucleus. The slides
were rinsed three times in PBS and treated with the
SlowFade Antifade Kit (Molecular Probes, Life Technol-
ogies Inc. Carlsbad, CA, USA) according to the manu-
facturer’s specifications.
Long-lived protein degradation assay
The long-lived protein degradation assay was modified
from published procedures [16,17]. Cells were plated at
40,000 cells per well on 12-well plates. Long-lived pro-
teins were labeled by removing the media, rinsing the
cells once with PBS and culturing in the presence of 1
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ml leucine-free media containing 10% serumand 5 μCi/
ml [3H]-leucine for 48 hours. After the labeling media
was removed, unincorporated radioisotopes and
degraded amino acids were removed by rinsing the plate
three times with PBS. Short-lived proteins were depleted
by culturing the labeled cells with 1 ml Opti-MEM con-
taining 4% serum and 2 mM cold leucine for 24 hours.
The chase medium was removed, cells were rinsed once
with PBS and additives were added in Opti-MEM/4%
serum. Aliquots of the medium were removed at 24
hours, BSA was added to 3 mg/ml final concentration
and trichloroacetic acid (TCA) was added to 10% final
concentration. Proteins were precipitated by incubating
at 4°C for 1 hour. Precipitates were recovered by centri-
fugation at 15,000×g for 5 minutes at 4°C. Supernatants
were collected and pellets were washed with cold 20%
TCA. The washes were combined with the supernatants
and this fraction represented small cleaved protein frag-
ments. PBS containing 0.5% Triton-X100 was added to
the cells on the plate in order to recover counts asso-
ciated with the cells. After a 1-hour incubation, the
lysate was removed and the wells were rinsed with PBS
containing 0.5% Triton-X100. TCA precipitations were
then performed on the protein lysates as described
above. Finally, SDS-PAGE lysis buffer was added to the
wells to collect any remaining counts. TCA precipitates
were air-dried and then resuspended in 0.1 N NaOH
prior to counting. Aliquots of all fractions were counted
with a scintillation counter. Proteolysis was determined
as the ratio of non-TCA precipitable counts to the total
counts in each well.
Cell-based proteasome activity assay
Cells were plated in black 96-well plates (Packard Bios-
ciences, Meriden, CT, USA) at 5,000 cells per well. They
were cultured in Opti-MEM containing 4% serum with
chloroquine 1 hour prior to adding 10 ng/ml TNFa.
After 22 hours, the media were removed and cells were
cultured in EBSS buffer (120 mM NaCl, 5.4 mM KCl,
0.81 mM MgSO4, 1 mM NaH2PO4, 5.5 mM D-glucose,
0.2 mM CaCl2, 25 mM HEPES) containing the indicated
additives. For the 2-hour proteasome assays, there was
no prior treatment with the additives in Opti-MEM.
Where indicated, epoxomicin - an inhibitor of the chy-
motrypsin-like activity of the 20S proteasome [18] - and
calpain inhibitor X1 were added for 1 hour prior to the
addition of TNFa. Proteolytic activity was determined
by the addition of the synthetic peptide Suc-Leu-Leu-
Val-Tyr-AMC (LLVY) prepared in EBSS and digitonin
directly to the wells such that the final concentration of
substrate was 50 μM and that of digitonin was 13.3 μg/
ml. Fluorescence measurements were performed every 5
minutes over 45 minutes on a SpectraMax M5 micro-
plate reader (Molecular Devices, Sunnyvale, CA, USA).
The excitation wavelength was 355 nm and the emission
wavelength was 465 nm. Proteasome activity was calcu-
lated from slopes of the change in fluorescence over the
change in time. In all cases, the slope of non-induced
cells was set at 100%.
XTT assay
Fibroblasts were plated at 3,000 cells per well in 96-well
plates. Quadruplicate wells were treated for 72 hours
with additives as indicated in the figure legends, and
their viability was determined with an XTT assay as
described elsewhere [10].
Statistical analysis
Results are plotted as the mean with the standard error
of the mean. Significant differences between groups
were determined using the Student t test. P < 0.05 was
considered significant.
Results
TNFa stimulates the acute endoplasmic reticulum stress
response in RA synovial fibroblasts
Since it has been reported that RA synovial fibroblasts
are relatively resistant to ER stress [8,9] and TNFa-
induced reactive oxygen species accumulation has been
shown to stimulate the UPR in murine fibrosarcoma
L929 cells [19], we asked whether TNFa modulated the
UPR of RA synovial fibroblasts. It has been suggested
that the cell senses the severity of ER stress by integra-
tion of signals from the three different pathways in the
UPR. The molecules that sense ER stress are PERK,
IRE1 and ATF6. In the nonstressed cell, these molecules
are maintained in an inactive state by association with
the ER chaperone protein Bip. When ER stress occurs,
Bip preferentially binds to aberrantly folded proteins
that accumulate in the ER, thereby freeing the sensors
to activate their signaling pathways.
We evaluated the expression of signature UPR mar-
kers within each of the three initiation pathways in
synovial fibroblasts derived from patients with RA.
These included eIF2a that is phosphorylated by active
PERK, Xbp1 mRNA that has an intron removed by
active IRE1a, and ATF6 protein that is proteolytically
processed to its active form in the golgi in response to
ER stress. Additionally, we examined expression of the
ER chaperone protein Bip/GRP78 and the proapoptotic
transcription factor CHOP. We observed that expression
of phosphorylated eIF2a, the active/cleaved forms of
ATF6 proteins and Bip protein were all increased in RA
synovial fibroblasts chronically stimulated by TNFa
compared with nonstimulated cells (Figure 1a).
Although nonstimulated or TNFa-stimulated RA syno-
vial fibroblasts primarily expressed RNA encoding the
nonactive form of Xbp, a small amount of RNA
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Figure 1 Rheumatoid arthritis synovial fibroblasts exhibit acute endoplasmic reticulum stress. (a) Synovial fibroblasts from patients with
rheumatoid arthritis (RA) were stimulated or not with 10 ng/ml TNFa for 72 hours prior to protein isolation. After fractionation of the lysates by
SDS-PAGE, they were immunoblotted and probed for expression of phosphorylated eukaryotic initiation factor 2a (peIF2a), activation of
transcription factor 6 (ATF6), Bip or tubulin. Results are representative of at least three different RA lines. (b) Cells were cultured for 72 hours with
or without the addition of 10 ng/ml TNFa or 2 μg/ml tunicamycin. RNA was isolated, reverse-transcribed and amplified for Xbp1, Edem1, CHOP
or actin. Xbp1 amplification products were subsequently subjected to Pst1 cleavage before analysis on agarose gels. Results shown are
representative of four different RA lines. (c) Fibroblasts were treated with 10 ng/ml TNFa or were left untreated for 24 or 72 hours prior to the
isolation of cellular lysates. Following SDS-PAGE and immunoblotting, band intensities of peIF2a were determined and normalized to tubulin
levels to compensate for loading differences. The normalized peIF2a levels of TNFa-stimulated cells were then compared with the
nonstimulated control. Filled circles, RA synovial fibroblasts at 24 hours; open circles, RA synovial fibroblasts at 72 hours; filled squares, control
fibroblasts at 24 hours; open squares, control fibroblasts at 72 hours. Significant differences in TNFa-stimulated cultures compared with non-
induced cultures: *P < 0.05. NS not significant.
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encoding the active form was consistently detected (Fig-
ure 1b). Further evidence that RA synovial fibroblasts
expressed active Xbp1 was obtained by amplification of
one of its putative targets, Edem1 [20]. Unlike the
results reported for the fibrosarcoma cells [19], CHOP
mRNA was not increased in the presence of TNFa.
TNFa-stimulated synovial fibroblasts treated with the
classical ER stress inducer tunicamycin, however,
expressed increased levels of cleaved Xbp1 and CHOP
mRNA, confirming that stimulated synovial fibroblasts
were capable of eliciting a full ER stress response.
To determine whether RA synovial fibroblasts had a
different ER stress response than control fibroblasts we
further examined one of the ER stress markers. Phos-
phorylated eIF2a was present at significantly higher
levels in RA synovial fibroblasts stimulated with TNFa
compared with nonstimulated RA synovial fibroblasts (P
< 0.05; Figure 1c). Dermal and osteoarthritis synovial
fibroblasts did not show a significant induction of phos-
phorylated eIF2a upon TNFa stimulation (P = 0.17).
These results indicated that TNFa potentiated the
acute (protective) ER stress response in RA synovial
fibroblasts and that nonstimulated synovial cells grown
out from the synovium are undergoing ER stress. This
suggests the possibility that in vivo activation of synovial
fibroblasts results in an acute ER stress response.
TNFa stimulates macroautophagy
In the previous section, we showed that the three arms
leading to the UPR are induced to varying degrees by
TNFa. The enhanced state of acute ER stress response
in TNFa-stimulated RA synovial fibroblasts suggested
that TNFa may influence protein degradation pathways.
Depending on the cell type and mode of induction of
ER stress, both the ubiquitin/proteasome pathway and
the lysosome/autophagy pathway are stimulated in
response to ER stress [5].
To determine whether TNFa affected autophagy in
fibroblasts, we analyzed the macroautophagy marker
LC3 by SDS-PAGE and immunoblotting. During the
early stages of autophagy, the LC3 cytosolic form
(LC3-I) is conjugated with phosphatidylethanolamine,
resulting in the faster migrating LC3-II form [21]. As
LC3-II itself is degraded by autophagy, a block in late-
stage autophagy will result in its accumulation [22].
p62/SQSTM1 is another marker used for determining
autophagic flux [23]. It contains multiple binding
domains, including those for ubiquitinated proteins
and LC3, and is involved in targeting proteins for
degradation. p62 becomes incorporated into autopha-
gosomes as they are forming and is degraded during
autophagy. Figure 2a is a representative western blot
illustrating that both LC3 forms and p62 were present
in RA synovial fibroblasts.
We determined the total amount of LC3 in response
to the various treatments. LC3 levels in TNFa-stimu-
lated cells were decreased compared with nonstimulated
cells (P < 0.01). In contrast, LC3 levels were increased
when the autophagy inhibitors chloroquine, a compound
that blocks autophagy completion by interfering with
the function of lysosomes [11] (P < 0.01), or 3-MA, a
compound that blocks macroautophagy (P < 0.05), were
included with TNFa (Figure 2b). There was a statisti-
cally significant increase in the amount of the LC3-II
macroautophagy indicator band relative to the total LC3
when cells were cultured with TNFa over an extended
period of time (P = 0.001). This autophagy-stimulating
effect of TNFa occurred in all fibroblast lines tested
(controls as well as RA). When chloroquine was
included in addition to TNFa, a further increase in
LC3-II relative to total LC3 levels was observed (P <
0.001). However, no significant difference was observed
when the macroautophagy inhibitor 3-MA was included
with TNFa compared with TNFa alone (P = 0.37; Fig-
ure 2c). This is probably because 3-MA functions
upstream of autophagosome formation. The fact that
there was a further accumulation of LC3-II in the pre-
sence of chloroquine indicated that TNFa stimulated
LC3 processing [21]. In agreement with this, qualitative
immunofluorescence staining revealed increased LC3
staining with TNFa (Figure 2d). Together, the data sug-
gest that macroautophagy is induced by TNFa.
Inhibition of autophagy in the presence of TNFa results
in proteasome activation in RA synovial fibroblasts
To directly test whether the proteasome was activated
by TNFa, a cell-based assay was used to measure activ-
ity of the proteasome [15]. The substrate used in this
assay, LLVY, is a substrate for both the chymotrypsin-
like proteasome activity [24] as well as calpain activity
[25]. It was therefore necessary to determine the specifi-
city for this substrate. The specific proteasome inhibitor
epoxomicin inhibited the activity by 97 to 98% while the
cell-permeable calpain inhibitor XI slightly increased the
activity (Figure 3a). This observation confirmed that the
majority of the activity measured by this assay was attri-
butable to the proteasome. Proteasome activity measure-
ments were performed at 2 hours to check for a direct
effect of inhibitors on the proteasome and at 24 hours, a
time point used for other assays in this study. Our
results revealed that in some RA synovial fibroblasts,
proteasome activity was increased in the presence of
TNFa (Figure 3b). However, this increase was not statis-
tically significant.
We confirmed that the assay did not measure proteo-
lysis resulting from autophagy by including the autop-
hagy inhibitor chloroquine (Figure 3c). Surprisingly,
when chloroquine was included in addition to TNFa,
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Figure 2 TNFa affects autophagy. Lysates from fibroblasts stimulated or not with 10 ng/ml TNFa, 12.5 μM chloroquine (CQ) or 4 mM
3-methyladenine (3-MA) for 24 or 72 hours were analyzed by immunoblotting. (a) A representative immunoblot probed with antibodies to
microtubule-associated protein 1 light chain 3 (LC3), p62 or tubulin. Results are representative of at least three different rheumatoid arthritis (RA)
lines. (b) The amount of total LC3 was determined from quantification of LC3-I and LC3-II. Protein loading was corrected by quantification of
tubulin. The ratio of total LC3 in TNFa-stimulated cells is compared with their nonstimulated controls. Filled circles, RA lines at 24 hours; open
circles, RA at 72 hours; filled squares, control at 24 hours; open squares, control at 72 hours. Significant differences between TNFa-stimulated
cultures compared with either non-induced cultures or with cultures that included 3-MA or CQ in addition to TNFa: *P < 0.05, **P < 0.01.
(c) The ratio of LC3-II to total LC3 was determined by quantification of the band intensities using ImageJ software. Filled circles, RA synovial
fibroblasts at 24 hours; open circles, RA synovial fibroblasts at 72 hours; filled squares, control fibroblasts at 24 hours; open squares, control
fibroblasts at 72 hours. Significant differences between TNFa-stimulated cultures compared with either non-induced cultures or with cultures
that included CQ in addition to TNFa: *P < 0.05, **P < 0.01, ***P < 0.001. (d) Fibroblasts grown on chamber slides for 24 hours with or without
10 ng/ml TNFa were examined by fluorescence microscopy for LC3. Nuclei were visualized with DAPI. Results are representative of three lines.
Ctl, control.
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control and RA fibroblasts responded differently (P =
0.01). A further increase in proteasome activity was
observed in some RA synovial fibroblasts while a signifi-
cant decrease in proteasome activity was observed in all
control fibroblasts compared with non-induced cells (P
< 0.05; Figure 3d). This observation indicates that TNFa
does not significantly increase proteasome activity
directly. When autophagy is blocked, however, protea-
some activity increases in RA synovial fibroblasts, possi-














Figure 3 Proteasome activity is increased by TNFa stimulation and lysosome inhibition. (a) Validation of the chymotrypsin activity assay.
Fibroblasts were cultured in EBSS for 2 hours with the addition of 0.5 μM epoximicin or 50 μM calpain inhibitor XI. The substrate Suc-Leu-Leu-
Val-Tyr-AMC and digitonin were then added to the wells and fluorescence was measured every 5 minutes for a 45-minute period. (b) Fibroblasts
were cultured with or without 10 ng/ml TNFa for 2 or 24 hours before substrate addition. Slopes were determined and relative proteasome
activity is represented as the slope of TNFa-induced cells relative to their non-induced controls. Ctl, control; RA, rheumatoid arthritis. (c)
Fibroblasts were cultured with 12.5 μM chloroquine (CQ) for 2 or 24 hours prior to addition of the substrate. Results are presented as the ratio of
the activity in the presence of CQ compared with the absence of CQ. (d) Fibroblasts were cultured for 1 hour with 12.5 μM CQ before the
addition of 10 ng/ml TNFa for 2 or 24 hours. Results are presented as the ratio of the activity in the presence of CQ plus TNFa compared with
that in the presence of TNFa. Significant differences in TNFa-stimulated compared with non-induced cultures of control cells or significant
differences between the response of control cultures compared with the response of RA synovial fibroblast cultures: *P < 0.05, **P < 0.01.
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RA synovial fibroblasts exhibit increased proteolysis of
long-lived proteins when autophagy is blocked in the
presence of TNFa
Our results suggested that TNFa induced LC3 proces-
sing in all fibroblasts in a manner consistent with autop-
hagy upregulation, yet had little effect on proteasome
activity. To confirm these observations, we examined
the influence of TNFa on the flux of long-lived proteins
[23]. Proteins degraded by autophagy are typically long-
lived while those degraded by the proteasome are short-
lived [26]. In preliminary experiments, we included inhi-
bitors of the proteasome, autophagy or both to deter-
mine the source of the counts. These experiments
revealed that the proteolysis measured by this technique
could be partly inhibited by a proteasome inhibitor in
addition to chloroquine, suggesting our assay measured
degradation of long-lived proteins occurring through
either the autophagy or proteasome pathways.
Interestingly, the majority of the proteolysis in the RA
lines could not be inhibited by either inhibitor alone
(Figure 4a). We therefore examined the possibility that
the autophagy and proteasome protein degradation
pathways influenced each other. This was accomplished
by comparing the proteolysis remaining when the inhi-
bitors were added separately with that when they were
added together. In control cells, the remaining proteoly-
sis was the same regardless of whether the inhibitors
were added separately or together. In contrast, RA lines
had less proteolysis remaining when the inhibitors were
added together compared with when they were added
separately (Figure 4b). This observation suggested that
the two protein degradation pathways functioned inde-
pendently of each other in control cells whereas they
influenced each other in RA synovial fibroblasts.
As shown in the compiled results of four different RA
synovial fibroblast lines and three different control fibro-
blast lines (Figure 4c), TNFa by itself had minimal effect
on the degradative flux of long-lived proteins. RA syno-
vial fibroblasts had significantly more proteolysis
remaining compared with control fibroblasts following
either lysosome inhibition with chloroquine (P < 0.05)
or proteasome inhibition with a proteasome inhibitor (P
< 0.01). This factor suggested that RA synovial fibro-
blasts were better able to compensate for the inhibition
of either protein degradation pathway than control
fibroblasts. This compensation may be relevant to the
survival of RA synovial fibroblasts.
Ubiquitinated proteins accumulate following proteasome
or lysosome inhibition
Although ubiquitinated proteins are considered to be
primarily degraded by proteasomes, there is increasing
evidence that they are also degraded by autophagy
[27,28]. We assessed the presence of ubiquitinated
proteins in RA synovial fibroblasts by western blot ana-
lysis as a complimentary measure of protein degradative
pathway activity. TNFa had no effect on the accumula-
tion of ubiquitinated proteins. Inhibition of proteasome
activity in the presence of TNFa, however, resulted in a
time-dependent (24-hour to 72-hour) build-up of ubi-
quitinated proteins (Figure 5a). Relative amounts of ubi-
quitinated proteins in cells cultured with protein
degradation pathway inhibitors compared with TNFa-
treated cells at 72 hours are shown in Figure 5b.
Although inhibition of the proteasome resulted in a
greater build-up of ubiquitinated proteins (P < 0.01), a
significant build-up was also observed when autophagy
was inhibited in the presence of TNFa (P < 0.05) - sug-
gesting both protein degradation pathways are utilized
in the clearance of ubiquitinated proteins. The fact that
the banding patterns of proteins on the gel appears to
be similar in proteasome-inhibited or lysosome-inhibited
(chloroquine) cells suggests that many ubiquitinated
proteins may be degraded by either pathway.
Lysosome or proteasome inhibition affects expression of
endoplasmic reticulum stress markers
Cells use ubiquitination as a method for targeting
unwanted proteins for degradation. We therefore quer-
ied whether the build-up of ubiquitinated proteins
observed following inhibition of the proteasome or lyso-
some impacted the ER stress response of the RA syno-
vial fibroblasts. To address this question, we prepared
cellular lysates from fibroblasts treated with TNFa and
the various inhibitors for 24 hours and then examined
them by immunoblotting for the ER stress indicator
proteins phosphorylated eIF2a and cleaved ATF6. A
typical blot for phosphorylated eIF2a expression is
shown in Figure 6a. In the absence of TNFa, all of the
treatments were associated with at least a 16-fold
increase in the phosphorylated form of eIF2a compared
with eIF2a. In the presence of TNFa, however, the
phosphorylated eIF2a to eIF2a ratio was already
increased and there was only an additional threefold
further increase upon treatment with the known ER
stress inducer tunicamycin or inhibition of autophagy or
proteasome. At 72 hours there was significantly
increased phosphorylated eIF2a expression when cells
were cultured with chloroquine (P < 0.01), epoxomicin
(P < 0.01) or tunicamycin (P = 0.05) in addition to
TNFa (Figure 6b). Surprisingly, the amount of cleaved/
active ATF6 decreased as early as 24 hours after inhibi-
tion of either the proteasome or autophagy (Figure 6c).
We detected spliced (active) versions of Xbp1 mRNA
upon amplification (data not shown). CHOP expression
was significantly increased when cells were cultured in
TNFa in the presence of proteasome inhibitor or tuni-
camycin (P < 0.05). Together these results suggest that
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Figure 4 Rheumatoid arthritis synovial fibroblasts exhibit increased proteolysis of long-lived proteins when autophagy isblocked in
the presence of TNF-a. (a) The source of the counts in the long-lived protein degradation assay was determined by comparing the protein
flux of long-lived proteins for two rheumatoid arthritis (RA) lines and two control (Ctl) lines cultured for 24 hours with 10 ng/ml TNFa with that
of cells cultured with 12.5 μM chloroquine (CQ) or 0.5 μM proteasome inhibitor (PI) in addition to 10 ng/ml TNFa. (b) The effect of the protein
degradation pathways on each other in RA synovial fibroblasts and control fibroblasts was determined by comparing the proteolysis remaining
after the addition of 12.5 μM CQ or 0.5 μM PI to separate wells or the same well of the same cell line for 24 hours. (c) The proteolysis remaining
after cells were cultured without TNFa or with12.5 μM CQ or 0.5 μM PI in addition to 10 ng/ml TNFa was compared with that when cells were
cultured with 10 ng/ml TNFa for 24 hours. This was determined for four RA lines and three control lines. Significant differences in control lines
compared with RA synovial fibroblast lines: *P < 0.05, **P < 0.01.
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Figure 5 Ubiquitinated proteins build-up in rheumatoid arthritis synovial fibroblasts with inhibited proteasome or autophagy
pathways. (a) Lysates (3 μg) from synovial fibroblasts cultured as indicated with 10 ng/ml TNFa, 0.5 μM proteasome inhibitor (PI) or 12.5 μM
chloroquine (CQ) for 24 or 72 hours were immunoblotted and probed for ubiquitinated proteins. (b) Quantification of the blots was determined
by ImageJ software. These results are the mean and standard deviation of three different experiments. Significant differences in TNFa-stimulated
cultures compared with cultures where PI or the autophagy inhibitor CQ was included in addition to TNFa: *P < 0.05, **P < 0.01.
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Figure 6 Lysosome or proteasome inhibition results in endoplasmic reticulum stress. (a) Rheumatoid arthritis (RA) synovial fibroblasts
were cultured with 2 μg/ml tunicamycin, 0.5 μM epoxomicin, 12.5 μM chloroquine (CQ) or 10 mM 3-methyladenine (3-MA) for 1 hour prior to
the addition or not of 10 ng/ml TNFa for 24 hours. A representative blot probed for expression of phosphorylated eukaryotic initiation factor 2
alpha (peIF2a) or eukaryotic initiation factor 2 alpha (eIF2a) is shown. Blots were scanned and analyzed by ImageJ software. (b) The relative
amount of phosphorylated eIF2a in cells stimulated with 12.5 μM CQ, 10 mM 3-MA, 0.5 μM epoxomicin or 2 μg/ml tunicmycin in addition to
TNFa was determined using tubulin as a loading control. These were then compared with the peIF2a levels in TNFa-stimulated control cells.
Significant differences in TNFa-stimulated cultures compared with cultures where the autophagy inhibitors CQ or 3-MAaproteasome inhibitor (PI)
or tunicamycin were included in addition to TNFa: *P < 0.05, **P < 0.01. (c) The effect of 12.5 μM CQ, 10 mM 3-MA, 0.5 μM epoxomicin or 2
μg/ml tunicmycin in addition to TNFa on the expression of the cleaved/active form of ATF6 was determined. Blot shown is representative of at
least three different lines. (d) CHOP mRNA levels were determined in cells that had been stimulated for 24 hours with the inhibitors as indicated.
They were compared with nonstimulated cells. The mean and standard deviation of CHOP expression in three different lines is shown.
Significant differences in TNFa-stimulated cultures compared with cultures where PI or tunicamycin was included in addition to TNFa: *P < 0.05.
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both the proteasome and autophagy protein degradation
pathways influence the ER stress response of RA syno-
vial fibroblasts.
Proteasome inhibition in the presence of TNFa affects
expression of autophagy markers
In the absence of TNFa, total LC3 levels were decreased
by culture with the known ER stressor tunicamycin or
epoxomicin and, as expected, were increased with the
autophagy inhibitors 3-MA or chloroquine (Figure 7a).
In contrast, in the presence of TNFa, total LC3 levels
were significantly increased with the autophagy inhibi-
tors (Figure 2b) or proteasome inhibition (P < 0.01; Fig-
ure 7b). Expression of p62 was also significantly
increased relative to TNFa when the proteasome was
inhibited (P < 0.05; Figure 7c). As shown in Figure 7d,
there was an excellent linear correlation between the
amount of LC3 relative to control and the ratio of LC3-
II relative to total LC3 in the absence of TNFa. This
correlation was lost when TNFa was included but was
regained when either the proteasome inhibitor epoxomi-
cin or the macroautophagy inhibitor 3-MA was
included, suggesting that the decreased LC3 levels
observed in the presence of TNFa were attributable to
proteasome activity as well as macroautophagy.
Increased resistance to proteasome and autophagy/
lysosome inhibitors by RA synovial fibroblasts
In this study we have shown that synovial fibroblasts use
both the autophagy and proteasome degradation path-
ways. To determine the biological significance of these
pathways for fibroblast viability, we treated the cells for
72 hours with the proteasome inhibitor MG132 (0.5
μM), the ER stress inducer tunicamycin (2 μg/ml), the
lysosome inhibitor chloroquine (12.5 μM), or the macro-
autophagy inhibitor 3-MA (4 mM) in the presence or
absence of TNFa, and then assessed their viability by an
XTT assay. As it had been reported that RA synovial
fibroblasts were more resistant to ER stress inducers
than osteoarthritis synovial fibroblasts, we included
three osteoarthritis synovial fibroblast lines and three
skin fibroblast lines in our experiments as controls. An
XTT assay determined that there was no difference in
TNFa sensitivity between the RA synovial fibroblasts
and the control fibroblast lines (P = 0.43). TNFa-stimu-
lated RA synovial fibroblasts cultured with the known
ER stress inducer tunicamycin were significantly more
viable than similarly treated control cells (P < 0.05; Fig-
ure 8a). Decreased viability occurred with MG132,
chloroquine and 3-MA, confirming that both the protea-
some and lysosome degradation pathways were used by
fibroblasts to maintain their viability.
Interestingly, unstimulated RA synovial fibroblasts
were relatively resistant to the proteasome inhibitor
MG132 and there was a significant difference between
the viability of control fibroblasts compared with RA
synovial fibroblasts (P = 0.01; Figure 8b). This suggested
that an alternative protein degradation system such as
the lysosome/autophagy pathway was sufficient to main-
tain viability of RA synovial fibroblasts in the absence of
TNFa. In the presence of TNFa, however, MG132 was
significantly more effective at decreasing cell viability in
all fibroblasts (P < 0.01) - suggesting that, under these
conditions, the proteasome degradation pathway was
required to maintain fibroblast viability.
In the presence of TNFa, RA synovial fibroblasts
were more resistant than control cells to the macroau-
tophagy inhibitor 3-MA (P < 0.05; Figure 8c) or the
lysosome inhibitor chloroquine (P < 0.05; Figure 8d).
In long-lived protein degradation assays, the contribu-
tion of macroautophagy to the total autophagy can be
approximated as the percentage of protein degradation
inhibitable by lysosome inhibitors that is also inhibita-
ble by the macroautophagy inhibitor 3-MA [29]. We
therefore used this approach to determine the contri-
bution of macroautophagy to cell survival. The contri-
bution of macroautophagy to the total autophagy was
greater in RA synovial fibroblasts than in the control
fibroblasts (78.5% vs. 57%) in the absence of TNFa. In
the presence of TNFa, the contribution of macroauto-
phagy to total autophagy declined to 32% in RA syno-
vial fibroblasts and to 34% in control fibroblasts. This
revealed that macroautophagy was the most important
autophagy pathway in RA synovial fibroblasts in the
absence of TNFa (78.5%). To rule out the possibility
that the decreased cellular viability after chloroquine
treatment was due to lysosome rupture resulting in the
release of cathepsins into the cytosol, we treated the
cells with a cathepsin inhibitor and observed that this
failed to rescue the cell viability (data not shown). This
indicated that intralysosomal cathepsins were contri-
buting to synovial fibroblast survival rather than caus-
ing cellular necrosis.
Together, the results from this set of experiments sug-
gested that macroautophagy played an important contri-
bution to the viability of RA synovial fibroblasts in the
absence of TNFa while proteasomes were important for
the viability of RA synovial fibroblasts in the presence of
TNFa. These results also suggest that, compared with
other fibroblasts, RA synovial fibroblasts have more
active proteasomal and lysosomal pathways.
Discussion
In this study, we examined the effect of TNFa on the
ER stress response and protein degradation pathways in
RA synovial fibroblasts to determine whether these are
potential mechanisms enabling the increased survival of
synovial fibroblasts in RA.
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Figure 7 Proteasome inhibition affects expression of autophagy markers. (a) Rheumatoid arthritis (RA) synovial fibroblasts were cultured
with 2 μg/ml tunicamycin, 0.5 μM epoxomicin, 12.5 μM chloroquine (CQ) or 10 mM 3-methyladenine (3-MA) for 1 hour prior to the addition or
not of 10 ng/ml TNFa for 24 hours. Cellular lysates were immunoblotted and probed for microtubule-associated protein 1 light chain 3 (LC3) or
tubulin as a loading control. Band intensities were quantified using ImageJ software. (b) The total amount of LC3 in the samples relative to that
in the TNFa sample was determined. Significant differences in TNFa-stimulated cultures compared with cultures where a proteasome inhibitor
was included in addition to TNFa: **P < 0.01. (c) The total amount of p62 in the samples relative to that in the TNFa sample was determined.
Significant differences in TNFa-stimulated cultures compared with cultures where a proteasome inhibitor was included in addition to TNFa: *P <
0.05. (d) LC3 results from (a) are plotted to show the relationship between total LC3 and LC3-II relative to total LC3: (i) without TNFa, (ii) with
TNFa, (iii) samples treated with proteasome inhibitor or macroautophagy inhibitor in the presence of TNFa shown in (ii) replotted with the
samples without TNFa treatment shown in (i) to show the restoration of the linear relationship between total LC3 and LC3-II relative to total
LC3. This suggests that the decreased LC3 levels observed in the presence of TNFa result from proteasome activity as well as macroautophagy.
In all cases, results are representative of at least three different experiments.
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We assessed the expression of molecules within each
of the UPR signaling pathways to determine whether the
pathways were activated. Following 72 hours of culture
with TNFa, we observed increased expression of phos-
phorylated eIF2a and the active form of ATF6 relative
to nonstimulated RA synovial fibroblasts. We also
observed a small amount of the spliced Xbp1 mRNA
but our experiments were not designed to determine
whether this was increased compared with nonstimu-
lated cells. CHOP expression was not significantly
altered with TNFa stimulation. Together, our results
suggest that fibroblasts are under acute ER stress and
that adjustments in the UPR signaling pathways in the
presence of TNFa are made to enable continued quality
control of the proteins passing through the ER.
Ubiquitin/proteasome and lysosome/autophagy are
two main pathways used by cells to eliminate proteins
causing ER stress. Given that TNFa is a key cytokine
driver in RA synovium, our aim was to determine
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Figure 8 Rheumatoid arthritis synovial fibroblasts are more resistant to proteasome and autophagy/lysosome inhibitors than other
fibroblasts. Fibroblasts (n = 6 rheumatoid arthritis (RA), n = 3 osteoarthritis, n = 3 dermal), stimulated or not with 10 ng/ml TNFa, were
cultured with (a) 2 μg/ml tunicamycin, (b) 0.5 μM MG132, (c) 4 mM 3-methyladenine (3-MA) or (d) 12.5 μM chloroquine (CQ) for 72 hours. An
XTT assay was performed and the survival of the cells was determined. Bars show standard error of the mean. Significant differences in control
fibroblasts compared with RA synovial fibroblasts or the response of TNFa-stimulated cultures compared with non-induced cultures: *P < 0.05,
**P < 0.01.
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degradation pathways. TNFa substantially modified LC3
expression, as evidenced by a decrease in total LC3
levels and an increase in the membrane-associated LC3
form in all fibroblasts. Our findings are supported by
the recent observation of the effect of TNFa on LC3
processing in Ewing sarcoma cells [30], MCF-7 cells
[31] and human skeletal muscle cells [32]. When chloro-
quine, a lysosome inhibitor, was added with TNFa, the
levels of the lower LC3 band were further increased.
p62 expression was in agreement with LC3 expression.
Since TNFa stimulated LC3 processing and turnover,
these results suggested that TNFa modulated the autop-
hagy pathway. As the cells in our experiments were cul-
tured under normal conditions with full serum, the
TNFa-modulated autophagy pathway is unlikely to be
the typical autophagy pathway activated under starvation
conditions and probably represents a constitutive
pathway.
To clarify the significance of autophagy-associated
protein modulation in TNFa-stimulated fibroblasts, we
determined the flux of long-lived proteins, generally
considered to represent autophagy flux. To determine
what this assay was measuring in our system, we initi-
ally inhibited the autophagy and proteasome degrada-
tion pathways separately. This inhibition revealed that
the assay measured degradation occurring through
both pathways as well as through a mechanism that we
have not yet identified. When we included chloroquine
and a proteasome inhibitor separately or together in
dermal fibroblasts, their effect was additive - suggest-
ing that the pathways proceeded independently of each
other. In RA synovial fibroblasts, however, the effect of
the inhibitors was not additive, suggesting that the
protein degradation pathways influenced each other.
RA synovial fibroblasts were significantly more resis-
tant than control fibroblasts to the inhibition of pro-
tein flux through either the autophagy pathway or the
proteasome degradation pathway. Together, these
results suggest that the protein degradation pathways
in RA synovial fibroblasts influence and compensate
for each other.
We employed a chymotrypsin-like activity assay to
gain further evidence that the proteasome was activated
in response to TNFa or chloroquine. We observed that
three of the four RA synovial fibroblast lines cultured
with TNFa or chloroquine for 24 hours had increased
chymotrypsin-like activity compared with those cultured
without TNFa. In contrast, three of four control lines
examined had decreased chymotrypsin-like activity com-
pared with those cultured without TNFa. This sug-
gested that, in RA synovial fibroblasts, TNFa is not only
capable of inducing expression of E3 ubiquitin ligases
involved in the ubiquitination pathway [33] but may
also stimulate the proteasome itself. This hypothesis is
in agreement with the long-lived protein degradation
assay that suggested RA synovial fibroblasts, but not
control fibroblasts, attempt to compensate for lysosome
inhibition by activating the proteasome. To date, most
studies examining the increased activity of the ubiqui-
tin/proteasome pathway have concentrated on the regu-
lation of the ubiquitination of proteins. A few studies,
however, have demonstrated that the proteasome itself
can be regulated [34-36]. Presently we do not know how
TNFa or lysosome inhibition stimulates proteasome
activity in RA synovial fibroblasts.
There are a number of examples where the autophagy
pathway is activated to compensate for proteasome inhi-
bition [37]. This may in fact happen in the RA synovial
fibroblasts cultured in the absence of TNFa as they are
relatively insensitive to proteasome inhibition. In con-
trast to our studies, a reduction of proteasomal activity
in cell lysates prepared from neuroblastoma SHSY5Y
cells [38] and SK-N-SH cells [39] treated with chloro-
quine has been reported. This was attributed to a pro-
teasome inhibitory affect of chloroquine. According to
our results, however, the proteasome in RA synovial
fibroblasts can be induced to degrade long-lived proteins
if autophagy is inhibited. This is the first example of
which we are aware where proteasome activation occurs
in response to autophagy inhibition. This suggests that
the proteasome and autophagy interface is deregulated
in RA synovial fibroblasts.
Treatment of fibroblasts with inhibitors of the two
main protein degradation pathways revealed that both
pathways contributed to fibroblast survival. TNFa sti-
mulated autophagy in all fibroblast lines and caused a
shift in the usage of the lysosome/autophagy pathways
from primarily 3-MA sensitive to more chloroquine sen-
sitive, suggestive of a switch from macroautophagy to
chaperone-mediated autophagy. This is supported by
studies of mouse embryo fibroblasts that also were
shown to undergo a decrease in macroautophagy upon
TNFa stimulation [29]. In the absence of TNFa, fibro-
blasts from patients with RA were significantly more
resistant to proteasome inhibition than control fibro-
blasts. In contrast, TNFa-stimulated fibroblasts required
an active ubiquitin/proteasome pathway for survival and
TNFa-stimulated synovial fibroblasts from patients with
RA were significantly more resistant to inhibition of the
lysosome/autophagy pathway and tunicamycin-induced
ER stress than other fibroblasts. We conclude that con-
stitutive lysosome/autophagy is more active in unstimu-
lated RA synovial fibroblasts compared with control
fibroblasts while ubiquitin/proteasome pathways are
more active in TNFa-stimulated RA synovial fibroblasts,
possibly enabling them to better tolerate ER stress than
non-RA fibroblasts. Unstimulated fibroblasts appear to
survive with a functional lysosome/autophagy pathway
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while TNFa stimulation necessitates a functional protea-
somal pathway.
There are a number of potential explanations for pro-
teasome requirement in the presence of TNFa. For
example, TNFa not only stimulates cytokine expression
but also results in accumulation of reactive oxygen spe-
cies that may damage proteins. Both of these scenarios
may necessitate the removal of additional aberrant or
excess proteins. Furthermore, the classical method for
NF-B activation requires that its inhibitor, IB, be
degraded by the proteasome [40]. As TNFa activates
NF-B, which in turn activates transcription of prosurvi-
val molecules, inhibition of the proteasome would result
in inhibition of NF-B and a change in the balance of
prosurvival molecules to proapoptotic molecules. In
some diseases, such as Alzheimer’s disease and inflam-
matory bowel disease, there is evidence that ER stress
can lead to an inflammatory response that is linked to
their pathogenesis [41,42]. The inflammatory response
serves to alert neighboring cells of the impending stress
to prevent further tissue damage. This has been sug-
gested to occur through ER stress-induced pathways
such as PERK-eIF2a that activate the NF-B signaling
pathway, the main pathway leading to inflammatory
responses. As RA is an inflammatory disease associated
with activated NF-B, the fibroblast-associated ER stress
possibly contributes to the initiation and inflammation
associated with the pathology of the disease. Interest-
ingly, proteasome inhibitors have been shown to be
effective in relieving inflammation in the rat models of
bacterial cell-wall-induced polyarthritis [43] and adju-
vant-induced arthritis [44].
Although hydroxychloroquine has been used for many
years in the treatment of RA, the base is slow acting
and how the treatment functions in controlling the dis-
ease is unclear. The bioavailability in patients with RA is
between 0.22 and 0.83 μM [45], considerably below the
12.5 μM chloroquine used in this study. Interestingly,
clinically relevant doses of chloroquine also inhibit lyso-
somal function, although at a slower rate and subopti-
mally [46]. This suggests that hydroxychloroquine may
be functioning in RA patients by partially inhibiting
autophagy, required for synovial fibroblast viability.
There is a report that LC3 may be degraded by pro-
teasome processing [47]. Our results support this report
as we observed increased LC3 levels following protea-
some inhibition and decreased levels when the protea-
some was activated with TNFa. Additionally, the
percentage of the lower form was increased in the pre-
sence of TNFa. As the lower form is membrane asso-
ciated while the upper form is cytoplasmic, possibly
only the upper form is available for degradation by the
proteasome and thus the apparent shift in LC3-I to
LC3-II occurs depending on the activity of the
proteasome. Similarly, although p62 was originally
reported to be specifically degraded by autophagy [48],
this marker has also been shown to increase when the
proteasome is inhibited [39]. If LC3 and p62 are
degraded by the proteasome, the macroautophagy path-
way would no longer be available and could explain the
shift from the usage of macroautophagy to other forms
of autophagy and proteasome-mediated protein degrada-
tion observed after TNFa stimulation in this study and
the mouse embryo fibroblast study [29].
Conclusions
Our findings suggest that fibroblasts are under continu-
ous ER stress that is increased by TNFa. The fibroblasts
use both the proteasome and autophagy pathways to
clear aberrant proteins and promote cell survival. Com-
pared with control fibroblasts, non-induced RA synovial
fibroblasts have more macroautophagy and are more
resistant to proteasome inhibition, suggesting that they
have more active lysosome/autophagy pathways enabling
them to compensate for proteasome inhibition. TNFa
stimulates autophagy in RA synovial fibroblasts, and
there appears to be a switch from primarily macroauto-
phagy usage to other forms of autophagy and depen-
dence on a functional proteasome. If completion of
autophagy is blocked, RA synovial fibroblasts are
uniquely able to compensate for the inhibition by upre-
gulating the proteasome, suggesting the proteasome and
autophagy interaction is deregulated in RA synovial
fibroblasts. This suggests that therapeutically targeting
both arms of the protein degradation pathways may be
of benefit in diseases such as RA that are associated
with an increased tolerance to ER stress.
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